The Impact of Air Filtration on Asthmatic Children

NCT03282864 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2020-03-23

No results posted yet for this study

Summary

This study uses a crossover study design to examine the impact of a two-week bedroom based indoor air filtration on the concentration of indoor airborne pollutants, personal exposure to airborne pollutants and health indicators among asthmatic children living in Shanghai, China

Conditions

  • Asthma in Children

Interventions

DEVICE

Bedroom air filtered by an air filtration device to remove airborne pollutants

The air in the bedroom of study subjects in the active comparator arm was processed by an air filtration device which pulled air through a pre-filter, a high efficiency particular air (HEPA) filter and an active carbon filter continuously. The air in the bedroom of subjects in the placebo arm was processed by a placebo air filtration device that looked identical to the real air filtration device but did not possess the HEPA filter and the active carbon filter. Each subject was assigned to the active comparator arm and the placebo arm in a randomized order with a two-week washout period scheduled in-between. The subjects, their guardians and the study staff that assessed the health indicators of the subjects were blinded to this order till the end of the study.

Sponsors & Collaborators

  • Underwriters Laboratory, Inc

    collaborator UNKNOWN
  • Duke University

    collaborator OTHER
  • Tsinghua University

    collaborator OTHER
  • University of Wisconsin, Madison

    collaborator OTHER
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Michael H. Bergin, PhD · Duke University

  • Junfeng Zhang, PhD · Duke University

  • James J. Schauer, PhD · University of Wisconsin, Madison

  • Yinping Zhang, PhD · Tsinghua University

  • Feng Li, MD · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
5 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-17
Primary Completion
2017-04-22
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03282864 on ClinicalTrials.gov